C22
Conditions
Interventions
Group 1: For this prospective, monocentric clinical study, six blood samples with one serum tube are required. Each tube requires 2.7 ml of whole blood. This corresponds to a total amount of 16.2 ml o
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age > 18 years - Elective chemosaturation with the EKZ
Exclusion criteria
Exclusion criteria: -Refusal of study inclusion by the patient -Existing pheochromocytoma (tumour in the adrenal gland), as this is a hormonally active tumour that releases catecholamines - the measurement results could therefore not be evaluated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laboratory diagnostic measurement of the catecholamine level during chemosaturation (pre- and post-filter) | — |
Secondary
| Measure | Time frame |
|---|---|
| -Check the correlation between the time of occlusion of the inferior vena cava and the catecholamine level -Measurement of inflammatory markers -Correlation of the catecholamine level with haemodynamic variables (blood pressure, cardiac output, heart rate) -Correlation of the catecholamine level in the blood with haemodynamic therapy (vasopressor/volume administration) | — |
Countries
Germany
Contacts
Public ContactMaximilian Dietrich
Universitätsklinikum Heidelberg
Outcome results
None listed